A detailed history of Neos Investment Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 40,582 shares of EXEL stock, worth $1.41 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
40,582
Previous 62,623 35.2%
Holding current value
$1.41 Million
Previous $1.41 Billion 25.16%
% of portfolio
0.03%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$21.96 - $27.6 $484,020 - $608,331
-22,041 Reduced 35.2%
40,582 $1.05 Billion
Q2 2024

Aug 14, 2024

BUY
$20.34 - $23.73 $897,400 - $1.05 Million
44,120 Added 238.45%
62,623 $1.41 Billion
Q1 2024

May 13, 2024

BUY
$20.17 - $23.93 $10,972 - $13,017
544 Added 3.03%
18,503 $439 Million
Q4 2023

Feb 13, 2024

BUY
$19.25 - $24.13 $345,710 - $433,350
17,959 New
17,959 $431 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.2B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.